(Date:11/23/2009)...ewswire/-InimexPharmaceuticals,Inc.announcedtodayt...tandCEO. ,, Abramsbringsmorethan25yearsofdrugdi...ventorofthenuclearmedicineimagingagent,Cardiolite,...wasManager,BiomedicalResearchWorldwide.In1996,Abra...esidentandCEOfrom1996to2006.AnorMEDdiscoveredandde...
(Date:11/20/2009)...untries have an opportunity to take the lead in tw...e University of Valencia (UV), working together wi...tive fabric of the Spanish biotechnology industry....ectors have more clout than those in English-speak...d and plants has been overlooked by the leading co...
(Date:11/20/2009)...20 Cell Therapeutics, In...at the Ninth Circuit Court of Appeals reversed a U... be allowed to pursue all of its claims against Th...t Court for trial. CTI filed a complaint against ...ment consultant for CTI,s product TRISENOX, in 200...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- Omeros Corporation (Nasda...ults for the third quarter ended September 30, 200...Omeros reported a net loss of $3.9 million, or $1....llion, or $2.54 per share, for the same period in ..., the Company reported a net loss of $15.5 million...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8... ultra-high definition has potential to revolution..., there was a glimpse into the,future of women,s h...gery,that was recorded for the first time using "4...mally Invasive Gynecology hosted by the AAGL. AAGL...cialists in minimally,invasive gynecological techn...
...t. 30 Nutrition 21, Inc.,(Nasdaq: NXXI ) today a...,president and general manager of the Company,s Di...s. McWilliams has more than 22 years of,experience...lopment within,the direct response industry. Mrs. ...development, sales strategy, vendor operations and...
...Oct. 30 Insmed Inc. (Nasdaq:,INSM), a developer o...y,reported results for the third quarter and nine-...ighlights, -- Follow-on Biologics Program ...dicines and Healthcare products Regulator...tudy for the Company,s second follow-on biologic ...
Other Biology Technology:Women's Surgery Recorded for the First Time on '4K' Digital Cinema is Presented at the AAGL Congress 2Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response 2Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response 3Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 2Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 3Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 4Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 5Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 6Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 7Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 8Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 9Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008 10..., 2008 A discovery by Canada-U.S. biophysicists w...n to little ,nano-machines, or ,nano-valves, in ou...tic illnesses that attack muscles, the central ner...current issue of the Proceedings of the National ...e Universit de Montral and the University of Chica...
...stmas, and make way for a "green" holiday. Here ar...ronmentally friendly, courtesy of the American Che...c society, and the ACS Green Chemistry Institute. ...sign of chemical products and processes that elimi...To reduce your own personal carbon footprint and n...
... and hormone treatment for infertility give an inc... This comes from a new study from the Norwegian I...time mothers from the Norwegian Mother and Child C... Normal risk , First-time mothers who had not... 5.2 % risk of pre-eclampsia. , Risk after mis...
Other Biology News:Researchers advance knowledge of little 'nano-machines' in our body 2Miscarriage and infertility treatment increase pre-eclampsia risk 2Normal Porcine Serum from Equitech-Bio
Anti-Foam Reagent from Promega
Viral CCI, Unconjugated, Fc Chimera from R&D Systems
GENOMIPHI V2 DNA AMP KIT 25RXN from GE Healthcare, formerly Amersham Biosciences
Biology Products: